Theriva Biologics, Inc. (TOVX) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -2.46M | -2.88M | -4.32M | -4.71M | -4.76M | -4.69M | -3.91M | -3.45M | -4.88M | -6.54M | -2.95M | -3.89M |
| Operating CF Margin % | -818.67% | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | 48.36% | 38.56% | -10.38% | -36.5% | 2.56% | 28.28% | -32.51% | 11.31% | 12.99% | -21.85% | 33.73% | 10.65% |
| Net Income | -2.04M | -2M | -4.36M | -13.06M | -4.32M | -4.45M | -7.73M | -8.32M | -5.17M | -5.49M | -3.3M | -5.08M |
| Depreciation & Amortization | 24K | 27K | 28K | 27K | 26K | 27K | 33K | 38K | 39K | 39K | 134K | 131K |
| Stock-Based Compensation | 135K | 153K | 0 | 0 | 100K | 162K | 177K | 172K | 160K | 145K | 0 | 0 |
| Deferred Taxes | 0 | -409K | 0 | 0 | -409K | -219K | -225K | -221K | -223K | -424K | -527K | -359K |
| Other Non-Cash Items | -247K | 892K | 540K | 9.01M | 141K | 302K | 3.58M | 3.88M | 310K | -1.29M | -1.43M | 578K |
| Working Capital Changes | -324K | -1.55M | -526K | -693K | -290K | -516K | 253K | 991K | -2K | 471K | 2.17M | 842K |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -397K | 209K | 161K | 139K | -440K | 144K | -200K | 369K | -190K | -83K | 107K | 259K |
| Cash from Investing | 0 | 0 | -19K | -16K | 0 | 0 | 0 | -1K | 0 | -56K | -129K | -9K |
| Capital Expenditures | 0 | 0 | -19K | -16K | 0 | 0 | 0 | -1K | 0 | -56K | -129K | -9K |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 3.87M | 8.46M | -148K | 6.81M | 3.07M | 7K | 3.72M | 1.77M | 0 | -1.46M | 1K | 2.14M |
| Debt Issued (Net) | -49K | 14K | 32K | 46K | 1.34M | 0 | 0 | -67K | 0 | 0 | 0 | -20K |
| Equity Issued (Net) | 2.3M | 6.55M | 279K | 6.69M | 0 | 7K | 3.72M | 1.84M | 0 | 62K | 1K | 2.16M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 1.61M | 1.89M | -459K | 71K | 1.73M | 0 | 0 | 0 | 0 | -1.52M | 0 | 0 |
| Net Change in Cash | 1.37M | 5.53M | -4.59M | 2.11M | -1.59M | -4.81M | -180K | -1.67M | -4.92M | -7.98M | -3.09M | -1.83M |
| Free Cash Flow | -2.46M | -2.88M | -4.34M | -4.73M | -4.76M | -4.69M | -3.91M | -3.45M | -4.88M | -6.6M | -3.08M | -3.9M |
| FCF Margin % | -818.67% | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | 48.36% | 38.56% | -10.86% | -36.92% | 2.56% | 28.89% | -26.96% | 11.48% | 13.12% | -20.85% | 31.01% | 10.73% |
| FCF per Share | -0.06 | -0.24 | -0.45 | -0.70 | -1.71 | -3.48 | -3.45 | -4.45 | -7.12 | -9.62 | -4.52 | -6.43 |
| FCF Conversion (FCF/Net Income) | 1.20x | 1.44x | 0.99x | 0.36x | 1.10x | 1.05x | 0.51x | 0.42x | 0.95x | 1.19x | 0.89x | 0.77x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |